From the ∗Department of Epidemiology and Public Health
†Institute for Genome Sciences, University of Maryland School of Medicine
‡Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine
§Department of Obstetrics and Gynecology, University of Maryland School of Medicine, Baltimore
¶Department of Epidemiology and Biostatistics, University of Maryland, College Park, MD
Conflict of Interest: S.T. has been a consultant for Biofire Diagnostics, Roche Molecular Diagnostics and Luca Biologics, receives royalties from UPTODATE and has received speaker honoraria from Roche Molecular Diagnostics and Medscape/WebMD.
Sources of Funding: National Institutes of Health: TL1-TR003100 and R01-AI119012.
Correspondence: Rebecca M. Brotman, PhD, MPH, Institute for Genome Sciences, Health Sciences Facility III, Room 3175, 670 West Baltimore St, Baltimore, MD 21201. E-mail: [email protected].
Received for publication September 16, 2022, and accepted January 30, 2023.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text, and links to the digital files are provided in the HTML text of this article on the journal’s Web site (http://www.stdjournal.com).
